Fierce Pharma
MAY 29, 2024
Pfizer chalked up a key win in its legal battle surrounding the now-recalled smoking cessation drug Chantix after a New York judge narrowed the scope of the arguments in play. | The company still faces some claims in a class action lawsuit over the now-recalled smoking cessation med Chantix.
David Bagga
MAY 29, 2024
How to Get Into Medical Device Sales: Ultimate Career Guide Home Blog How to Get Into Medical Device Sales: Ultimate Career Guide How to Get Into Medical Device Sales: Ultimate Career Guide If you are new to medical device sales and interested in getting a job in this field, here are some essential tips that […] The post How to Get Into Medical Device Sales: Ultimate Career Guide appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 29, 2024
After half a decade spent developing an automated manufacturing platform, Ori Biotech believes it's ready to make a mark on the cell and gene therapy field. | Ori has revealed an automated cell and gene therapy manufacturing platform. The company says its tech is flexible enough to transition between projects at various stages of development.
David Bagga
MAY 29, 2024
How to Get Medical Device Sales Jobs with No Experience? Home Blog How to Get Medical Device Sales Jobs with No Experience? How to Get Medical Device Sales Jobs with No Experience? Medical device sales become one of the best career options today. More and more people want to crack medical device sales jobs and […] The post How to Get Medical Device Sales Jobs with No Experience?
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
MAY 29, 2024
Neurocrine Biosciences’ dealmaking prospects may soon get another round of attention with the installment of a new CEO. | Neurocrine Biosciences' dealmaking prospects may get another round of attention with the installment of a new CEO. The neuroscience company's three-decade veteran Kevin Gorman will soon hand the top job to long-time BD chief Kyle Gano.
David Bagga
MAY 29, 2024
Medical device sales is a burgeoning market, with jobs that have an extremely high earning potential. In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Device Sales Rep in 2024? Home Blog How to Become A Medical Device Sales Rep in 2024? How to Become A […] The post How to Become A Medical Device Sales Rep in 2024?
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
David Bagga
MAY 29, 2024
Medical device sales is a burgeoning market, with jobs that have an extremely high earning potential. In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Sales Rep With No Experience 2024? Home Blog How to Become A Medical Sales Rep With No Experience 2024? How to […] The post How to Become A Medical Sales Rep With No Experience 2024?
Fierce Pharma
MAY 29, 2024
Stimulants are typically the go-to option for doctors prescribing treatments for attention-deficit hyperactivity disorder (ADHD). | Tris Pharma has won FDA approval for Onyda XR (clonidine hydrochloride). The extended-release oral suspension becomes the first liquid non-stimulant medication for ADHD and the only non-stimulant with nighttime dosing in the indication.
David Bagga
MAY 29, 2024
How Much Do Medical Device Sales Reps Make in 2024? Home Blog How Much Do Medical Device Sales Reps Make in 2024? How Much Do Medical Device Sales Reps Make in 2024? When looking for a medical device sales rep job, a common question is, ‘How much does a medical device sales rep earn? It’s […] The post How Much Do Medical Device Sales Reps Make in 2024?
Fierce Pharma
MAY 29, 2024
Amgen has made waves in the biosimilar field in recent years with its U.S.-first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. | Amgen has made waves in the biosimilar field in recent years with its U.S.-first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. But thanks to a new FDA approval, the company is nearing yet another biosimilar launch.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
MAY 29, 2024
A new J.D. Power ranking of commercial health plans found a major difference in customer satisfaction between the top and bottom-ranked health plans. The post J.D. Power: Customer Experience Gap Grows Among Commercial Health Plans appeared first on MedCity News.
PharmaVoice
MAY 29, 2024
A partnership between the cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could bring the manufacturing bottleneck under control, the CEOs said.
Fierce Pharma
MAY 29, 2024
Already weathering the complex biopharma landscape in the U.S.
pharmaphorum
MAY 29, 2024
In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
MAY 29, 2024
Deb Muro, CIO of El Camino Health, explained some of the ways her health system is using technology to make nurses’ jobs easier — including software that flags patients who are at risk of adverse outcomes and a tool that helps frontline nurse managers better engage with their staff. The post Inside the Tech El Camino Health Is Using to Fight the Nurse Burnout Crisis appeared first on MedCity News.
pharmaphorum
MAY 29, 2024
More consolidation in the digital health sector as Akili agrees a $34m takeover by Virtual Therapeutics, returning to private hands.
European Pharmaceutical Review
MAY 29, 2024
The European Commission (EC) has granted the first approval for an omalizumab biosimilar in Europe. Omlyclo ® (CT-P39) is authorised as a biosimilar referencing Xolair ®. CT-P39 is indicated for allergic asthma, chronic spontaneous urticaria (CSU), and chronic rhinosinusitis with nasal polyps (CRSwNP). The authorisation is based on clinical data, including findings from a Phase III clinical trial comparing Omlyclo ® to the reference product in patients with chronic spontaneous urticaria up to
pharmaphorum
MAY 29, 2024
AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol.
European Pharmaceutical Review
MAY 29, 2024
The safety and tolerability of rationally-designed live bacterial product (LBP) BMC128 combined with nivolumab has shown initial positive trends in non-small cell lung cancer (NSCLC), melanoma, or renal cell carcinoma (RCC), new data from an ongoing Phase I clinical trial suggests. Biomica’s microbiome -based immuno-oncology candidate and the anti-PD1 immune checkpoint inhibitor is being evaluated in eleven participants.
Nixon Gwilt Law
MAY 29, 2024
Healthcare delivery is changing, and digital health is revolutionizing healthcare, creating a burgeoning market opportunity for software-as-a-medical-device (SaMD) and digital therapeutic (DTx) products. These innovations can improve patient outcomes while creating revenue potential through direct-to-consumer sales, contracts with health plans, and existing billing codes like the remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) code sets.
MedCity News
MAY 29, 2024
Five ways stakeholders can promote screening and treatment for elevated Lp(a) in the future to improve overall cardiac disease mortality The post Why Prevention-Focused Strategies Are Key appeared first on MedCity News.
pharmaphorum
MAY 29, 2024
MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular degeneration (AMD).
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
MedCity News
MAY 29, 2024
In this episode, we’re joined by Randa Deaton, vice president of purchaser engagement at the Purchaser Business Group on Health. She talks about the organization’s new Comprehensive Maternity Care Common Purchasing Agreement. The post MedCity FemFwd: How Employers Can Improve Maternal Health Outcomes appeared first on MedCity News.
pharmaphorum
MAY 29, 2024
Amgen’s Bkemv is first FDA-approved biosimilar to AstraZeneca’s Soliris in the US, getting interchangeable status for rare diseases PNH and aHUS
Pharmaceutical Technology
MAY 29, 2024
The US FDA has set an action date of 27 November for the combination therapy of Roche’s inavolisib, Pfizer’s Ibrance, and fulvestrant.
MedCity News
MAY 29, 2024
Merck’s EyeBio acquisition brings a lead program ready for pivotal testing in diabetic macular edema. The therapy could pose competition to Eylea, the blockbuster Regeneron Pharmaceuticals eye drug. The post Merck Sees Pipeline Diversification Opportunity in $1.3B EyeBio Acquisition appeared first on MedCity News.
Pharmaceutical Technology
MAY 29, 2024
Ensifentrine is a first-in-class dual phosphodiesterase 3/4 inhibitor to treat chronic obstructive pulmonary disease (COPD).
PharmaTimes
MAY 29, 2024
Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation
Pharmaceutical Technology
MAY 29, 2024
The US FDA has approved Amgen's Bkemv as an interchangeable biosimilar to Soliris for the treatment of specific rare diseases.
PharmaVoice
MAY 29, 2024
As Novo Nordisk aims to secure its manufacturing foothold for GLP-1s, regulators are digging for clues of anti-competitive behavior.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
290 
Let's personalize your content